Form 4: ACM Research Director Xiao Xing Sells Shares Under 10b5-1 Trading Plan

Director Xiao Xing, associated with Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC), sold shares of ACM Research, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• Xiao Xing, a director at ACM Research, Inc., executed sales of Class A Common Stock on October 1, 2024, and October 2, 2024.
• The sales were conducted under a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC) on June 12, 2024.
• On October 1, 2024, 8,304 shares were sold at a weighted average price of $20.19, with prices ranging from $20.00 to $20.28.
• On October 2, 2024, 26,300 shares were sold at a weighted average price of $20.01, with prices ranging from $20.00 to $20.17.
• Following these transactions, SSTVC beneficially owns 3,403,906 shares.
• Xiao Xing disclaims beneficial ownership of the shares owned by SSTVC except to the extent of the reporting person's pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales by a director. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions executed under a pre-existing trading plan.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 trading plan provides a legal framework for insiders to sell shares without being accused of acting on non-public information.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small volume of shares sold compared to the total outstanding shares.

Key Dates